Moreover, 9D9 mAb increased the proportion and absolute number of CD8+ T cells producing granzyme B. Thus, reduced Treg function and increased CD8+ T cell effector function could also contribute to the remodeling of the tumor vasculature and the increase of TA-HEVs during anti-CTLA-4 therapy. The gene discussed is GZMB; the disease is neoplasm.